nach oben

Journal of Natural Medicines

Erschienen in:

01.04.2016 | Original Paper

The renoprotective effect of shichimotsukokato on hypertension-induced renal dysfunction in spontaneously hypertensive rats

verfasst von: Yue Ma, Makoto Fujimoto, Hidetoshi Watari, Mari Kimura, Yutaka Shimada

Erschienen in: Journal of Natural Medicines | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Antihypertensive treatment is highly important to prevent the progression of chronic kidney disease. Shichimotsukokato (SKT), a traditional Japanese medicine (i.e., Kampo formula), lowered systolic blood pressure (SBP) in experimental animal models of hypertension. However, its mechanism of action has not been fully elucidated. We investigated the potential renoprotective mechanism of SKT in spontaneously hypertensive rats (SHRs). Ten-week-old SHRs were randomly divided into four groups (six rats per group). In the SHR control group, the SBP increased remarkably during the 8-week experimental period. In the SHRs, SKT extract administered orally at a daily dose of 0.45 or 0.15 g/kg significantly suppressed the increase in SBP to the same extent as telmisartan administered orally at a daily dose of 0.01 g/kg. At the end of the experiment, blood, urine, and kidney cortex tissue samples were examined. The SKT treatment significantly decreased urinary albumin excretion to nearly the same level as the telmisartan treatment. A notable loss of chloride channel 5 (ClC-5), a chloride channel in the proximal renal tubules, occurred in the SHR control group. Thus, we concluded that SKT administration significantly ameliorated this decrease. The mechanism of SKT in reducing urinary albumin excretion is mediated, at least partly, by prevention of the loss of ClC-5 in the renal cortex of SHRs.

Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE (2014) Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis 7:75–88PubMedCentralCrossRefPubMed

Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group (2009) Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20:1813–1821PubMedCentralCrossRefPubMed

Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80:93–104PubMedCentralCrossRefPubMed

Lambers Heerspink HJ, Brinkman JW, Bakker SJ, Gansevoort RT, de Zeeuw D (2006) Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr Opin Nephrol Hypertens 15:631–636CrossRefPubMed

Deen WM, Lazzara MJ, Myers BD (2001) Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 281:F579–F596PubMed

Haraldsson B, Jeansson M (2009) Glomerular filtration barrier. Curr Opin Nephrol Hypertens 18:331–335CrossRefPubMed

Mathieson PW (2004) The cellular basis of albuminuria. Clin Sci (Lond) 107:533–538CrossRef

Miner JH (2011) Glomerular basement membrane composition and the filtration barrier. Pediatr Nephrol 26:1413–1417PubMedCentralCrossRefPubMed

Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, Graham D, Hawkins J, Nishizono R, Tanzer M, Wiggins J, Escobar GA, Rovin B, Song P, Gipson D, Kershaw D, Wiggins RC (2013) Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol 24:2081–2095PubMedCentralCrossRefPubMed

10.

Patrakka J, Tryggvason K (2007) Nephrin—a unique structural and signaling protein of the kidney filter. Trends Mol Med 13:396–403CrossRefPubMed

11.

Pätäri-Sampo A, Ihalmo P, Holthöfer H (2006) Molecular basis of the glomerular filtration: nephrin and the emerging protein complex at the podocyte slit diaphragm. Ann Med 38:483–492CrossRefPubMed

12.

Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attié T, Gubler MC, Antignac C (2002) Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160:131–139PubMedCentralCrossRefPubMed

13.

Gekle M (2005) Renal tubule albumin transport. Annu Rev Physiol 67:573–594CrossRefPubMed

14.

Park CH, Maack T (1984) Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest 73:767–777PubMedCentralCrossRefPubMed

15.

Birn H, Fyfe JC, Jacobsen C, Mounier F, Verroust PJ, Orskov H, Willnow TE, Moestrup SK, Christensen EI (2000) Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest 105:1353–1361PubMedCentralCrossRefPubMed

16.

Christensen EI, Birn H (2001) Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 280:F562–F573PubMed

17.

Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker RV (1999) Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent’s disease. Hum Mol Genet 8:247–257CrossRefPubMed

18.

Piwon N, Günther W, Schwake M, Bösl MR, Jentsch TJ (2000) ClC-5 Cl⁻-channel disruption impairs endocytosis in a mouse model for Dent’s disease. Nature 408:369–373CrossRefPubMed

19.

Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S, Guggino WB (2000) Mice lacking renal chloride channel, CLC-5, are a model for Dent’s disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9:2937–2945CrossRefPubMed

20.

Hiwara N, Uehara Y, Takada S, Kawabata Y, Ohshima N, Nagata T, Ishimitsu T, Gomi T, Goto A, Ikeda T, Yagi S, Omata M (1994) Antihypertensive property and renal protection by shichimotsu-koka-to extract in salt-induced hypertension in Dahl strain rats. Am J Chin Med 22:51–62CrossRefPubMed

21.

Bai F, Makino T, Ono T, Mizukami H (2012) Anti-hypertensive effects of shichimotsukokato in 5/6 nephrectomized Wistar rats mediated by the DDAH–ADMA–NO pathway. J Nat Med 66:583–590CrossRefPubMed

22.

Ono T, Kamikado K, Morimoto T (2013) Protective effects of Shichimotsu-koka-To on irreversible Thy-1 nephritis. Biol Pharm Bull 36:41–47CrossRefPubMed

23.

Nakagami H, Kiomy Osako M, Nakagami F, Shimosato T, Minobe N, Moritani T, Shimamura M, Miyake T, Shimizu H, Takeya Y, Morishita R (2010) Prevention and regression of non-alcoholic steatohepatitis (NASH) in a rat model by metabosartan, telmisartan. Int J Mol Med 26:477–481PubMed

24.

Deguchi K, Kurata T, Fukui Y, Liu W, Yun Z, Omote Y, Sato K, Kono S, Hishikawa N, Yamashita T, Abe K (2014) Long-term amelioration of telmisartan on metabolic syndrome-related molecules in stroke-resistant spontaneously hypertensive rat after transient middle cerebral artery occlusion. J Stroke Cerebrovasc Dis 23:2646–2653CrossRefPubMed

25.

The Society of Japanese Pharmacopoeia (2012) The Japanese pharmacopoeia sixteenth edition (JP XVI). Yakuji-Nippo, Tokyo

26.

Kimura M, Shibahara N, Hikiami H, Yoshida T, Jo M, Kaneko M, Nogami T, Fujimoto M, Goto H, Shimada Y (2011) Traditional Japanese formula kigikenchuto accelerates healing of pressure-loading skin ulcer in rats. Evid Based Complement Altern Med 2011:592791

27.

Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675CrossRefPubMed

28.

Nakai Y, Kido T, Hashimoto K, Kase Y, Sakakibara I, Higuchi M, Sasaki H (2003) Effect of the rhizomes of Atractylodes lancea and its constituents on the delay of gastric emptying. J Ethnopharmacol 84:51–55CrossRefPubMed

29.

Yanagi Y, Yasuda M, Hashida K, Kadokura Y, Yamamoto T, Suzaki H (2008) Mechanism of salivary secretion enhancement by Byakkokaninjinto. Biol Pharm Bull 31:431–435CrossRefPubMed

30.

Hultström M (2012) Development of structural kidney damage in spontaneously hypertensive rats. J Hypertens 30:1087–1091CrossRefPubMed

31.

Pavenstädt H, Kriz W, Kretzler M (2003) Cell biology of the glomerular podocyte. Physiol Rev 83:253–307CrossRefPubMed

32.

Huber TB, Benzing T (2005) The slit diaphragm: a signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 14:211–216CrossRefPubMed

33.

Chen HM, Liu ZH, Zeng CH, Li SJ, Wang QW, Li LS (2006) Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 48:772–779CrossRefPubMed

34.

Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z (2001) Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 44:874–877CrossRefPubMed

35.

Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z (2005) Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Am J Physiol Renal Physiol 289:F880–F890CrossRefPubMed

36.

Inoue BH, Arruda-Junior DF, Campos LC, Barreto AL, Rodrigues MV, Krieger JE, Girardi AC (2013) Progression of microalbuminuria in SHR is associated with lower expression of critical components of the apical endocytic machinery in the renal proximal tubule. Am J Physiol Renal Physiol 305:F216–F226CrossRefPubMed

37.

Kawachi H, Suzuki K, Miyauchi N, Hashimoto T, Otaki Y, Shimizu F (2009) Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome. Clin Exp Nephrol 13:275–280CrossRefPubMed

38.

Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R (1997) Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int 51:244–252CrossRefPubMed

39.

Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT Jr, Wang X, Greene T, Appel LJ, Lewis J; AASK Study Group (2006) Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 48:739–751CrossRefPubMed

40.

Dickson LE, Wagner MC, Sandoval RM, Molitoris BA (2014) The proximal tubule and albuminuria: really! J Am Soc Nephrol 25:443–453PubMedCentralCrossRefPubMed

41.

Amsellem S, Gburek J, Hamard G, Nielsen R, Willnow TE, Devuyst O, Nexo E, Verroust PJ, Christensen EI, Kozyraki R (2010) Cubilin is essential for albumin reabsorption in the renal proximal tubule. J Am Soc Nephrol 21:1859–1867PubMedCentralCrossRefPubMed

42.

Birn H, Christensen EI, Nielsen S (1993) Kinetics of endocytosis in renal proximal tubule studied with ruthenium red as membrane marker. Am J Physiol 264:F239–F250PubMed

43.

Zhou ZY, Tang YP, Xiang J, Wua P, Jin HM, Wang Z, Mori M, Cai DF (2010) Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol 131:154–164CrossRefPubMed

44.

Song J, Meng L, Li S, Qu L, Li X (2009) A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Vascul Pharmacol 50:185–193CrossRefPubMed

45.

Lee BC, Choi JB, Cho HJ, Kim YS (2009) Rehmannia glutinosa ameliorates the progressive renal failure induced by 5/6 nephrectomy. J Ethnopharmacol 122:131–135CrossRefPubMed

46.

Bai F, Makino T, Kono K, Nagatsu A, Ono T, Mizukami H (2013) Calycosin and formononetin from astragalus root enhance dimethylarginine dimethylaminohydrolase 2 and nitric oxide synthase expressions in Madin Darby Canine Kidney II cells. J Nat Med 67:782–789CrossRefPubMed

Titel: The renoprotective effect of shichimotsukokato on hypertension-induced renal dysfunction in spontaneously hypertensive rats
verfasst von: Yue Ma
Makoto Fujimoto
Hidetoshi Watari
Mari Kimura
Yutaka Shimada
Publikationsdatum: 01.04.2016
Verlag: Springer Japan
Erschienen in: Journal of Natural Medicines / Ausgabe 2/2016
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-015-0945-1

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2016

Optimization of combinations of ginsenoside-Rg1, ginsenoside-Rb1, evodiamine and rutaecarpine for effective therapy of mouse migraine

Simultaneous quantitative analysis of 12 methoxyflavones with melanogenesis inhibitory activity from the rhizomes of Kaempferia parviflora

Chemical composition, aroma evaluation, and inhibitory activity towards acetylcholinesterase of essential oils from Gynura bicolor DC.

Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice

Three new xanthones from the leaves of Garcinia lancilimba

In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5′-methylful-3′-yl)propane-1,2,3-triol